Gene: Piezo2 (piezo-type mechanosensitive ion channel component 2) Rattus norvegicus
Analyze
Symbol: Piezo2
Name: piezo-type mechanosensitive ion channel component 2
Description: Predicted to have cation channel activity and mechanosensitive ion channel activity; predicted to be involved in several processes, including cation transport, cellular response to mechanical stimulus, and detection of mechanical stimulus involved in sensory perception; predicted to localize to the plasma membrane; orthologous to human PIEZO2 (piezo type mechanosensitive ion channel component 2); INTERACTS WITH 17alpha-ethynylestradiol; acrylamide; benzo[a]pyrene.
Type: protein-coding
RefSeq Status: MODEL
Also known as: Fam38b; family with sequence similarity 38, member B; LOC307380; LOC688934; RGD1306866; similar to Hypothetical protein KIAA0233; similar to protein fam38b
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.01858,353,361 - 58,728,555 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.01857,576,278 - 57,949,635 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41859,147,791 - 59,531,873 (-)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.11859,220,826 - 59,402,111 (-)NCBI
Celera1854,616,241 - 54,988,723 (-)NCBICelera
Cytogenetic Map18q12.1NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
Position Markers
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome

Strain Variation

Strain Sequence Variants (Rnor 5.0)
Damaging Variants

Additional Information

External Database Links
Nomenclature History
 
More on Piezo2
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 1582973
Created: 2006-11-19
Species: Rattus norvegicus
Last Modified: 2019-04-23
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.